Scheer et al. observed an increase in the polysialylation of NCAM, while NCAM expression itself was not altered, and a subsequent increased invasion in the neuroblastoma cell line Kelly following MGO treatment [19]. The gene discussed is NCAM1; the disease is neuroblastoma.